RU2018114922A3 - - Google Patents

Download PDF

Info

Publication number
RU2018114922A3
RU2018114922A3 RU2018114922A RU2018114922A RU2018114922A3 RU 2018114922 A3 RU2018114922 A3 RU 2018114922A3 RU 2018114922 A RU2018114922 A RU 2018114922A RU 2018114922 A RU2018114922 A RU 2018114922A RU 2018114922 A3 RU2018114922 A3 RU 2018114922A3
Authority
RU
Russia
Application number
RU2018114922A
Other languages
Russian (ru)
Other versions
RU2754997C2 (ru
RU2018114922A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2015190849A external-priority patent/JP2017066061A/ja
Application filed filed Critical
Publication of RU2018114922A publication Critical patent/RU2018114922A/ru
Publication of RU2018114922A3 publication Critical patent/RU2018114922A3/ru
Application granted granted Critical
Publication of RU2754997C2 publication Critical patent/RU2754997C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2018114922A 2015-09-24 2016-09-22 Лечение очаговой алопеции RU2754997C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15186644 2015-09-24
JP2015-190849 2015-09-24
EP15186644.9 2015-09-24
JP2015190849A JP2017066061A (ja) 2015-09-29 2015-09-29 円形脱毛症治療剤
PCT/EP2016/072531 WO2017050891A1 (en) 2015-09-24 2016-09-22 Treatment of alopecia areata

Publications (3)

Publication Number Publication Date
RU2018114922A RU2018114922A (ru) 2019-10-28
RU2018114922A3 true RU2018114922A3 (enExample) 2019-12-11
RU2754997C2 RU2754997C2 (ru) 2021-09-08

Family

ID=57047187

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018114922A RU2754997C2 (ru) 2015-09-24 2016-09-22 Лечение очаговой алопеции

Country Status (27)

Country Link
US (3) US20180263986A1 (enExample)
EP (1) EP3352734B1 (enExample)
JP (1) JP6776345B2 (enExample)
KR (1) KR102728341B1 (enExample)
CN (1) CN108135834B (enExample)
AU (3) AU2016325388A1 (enExample)
BR (1) BR112018005771B1 (enExample)
CA (1) CA2998972A1 (enExample)
CY (1) CY1122837T1 (enExample)
DK (1) DK3352734T3 (enExample)
ES (1) ES2779762T3 (enExample)
HR (1) HRP20200472T1 (enExample)
HU (1) HUE049052T2 (enExample)
IL (3) IL312861A (enExample)
LT (1) LT3352734T (enExample)
MX (1) MX375024B (enExample)
MY (1) MY196541A (enExample)
PL (1) PL3352734T3 (enExample)
PT (1) PT3352734T (enExample)
RS (1) RS60365B1 (enExample)
RU (1) RU2754997C2 (enExample)
SG (1) SG10202111361TA (enExample)
SI (1) SI3352734T1 (enExample)
TW (1) TWI720022B (enExample)
UA (1) UA124192C2 (enExample)
WO (1) WO2017050891A1 (enExample)
ZA (1) ZA201801722B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021132598A1 (ja) * 2019-12-27 2021-07-01 ロート製薬株式会社 水性組成物
WO2023029943A1 (zh) * 2021-09-03 2023-03-09 星药科技(北京)有限公司 一种芳杂环化合物及其制备方法和用途
JP2025514747A (ja) * 2022-04-20 2025-05-09 レオ ファーマ アクティーゼルスカブ 前頭部線維性脱毛症の治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent
EP3061455B1 (en) * 2013-10-21 2018-11-28 Japan Tobacco, Inc. Therapeutic agent for ocular disease or prophylactic agent for ocular disease

Also Published As

Publication number Publication date
RU2754997C2 (ru) 2021-09-08
EP3352734B1 (en) 2020-01-15
SG10202111361TA (en) 2021-12-30
TWI720022B (zh) 2021-03-01
ES2779762T3 (es) 2020-08-19
KR20180054767A (ko) 2018-05-24
PL3352734T3 (pl) 2020-08-24
JP2018528238A (ja) 2018-09-27
AU2024204716A1 (en) 2024-07-25
NZ740690A (en) 2024-11-29
IL298520A (en) 2023-01-01
DK3352734T3 (da) 2020-03-30
CN108135834A (zh) 2018-06-08
MX2018003332A (es) 2018-08-16
AU2016325388A1 (en) 2018-03-29
RU2018114922A (ru) 2019-10-28
IL312861A (en) 2024-07-01
EP3352734A1 (en) 2018-08-01
CA2998972A1 (en) 2017-03-30
MX375024B (es) 2025-03-06
PT3352734T (pt) 2020-03-31
US20180263986A1 (en) 2018-09-20
UA124192C2 (uk) 2021-08-04
KR102728341B1 (ko) 2024-11-11
ZA201801722B (en) 2025-06-25
HRP20200472T1 (hr) 2020-09-18
RS60365B1 (sr) 2020-07-31
TW201717955A (zh) 2017-06-01
HUE049052T2 (hu) 2020-09-28
HK1257770A1 (en) 2019-10-25
JP6776345B2 (ja) 2020-10-28
US20240398809A1 (en) 2024-12-05
BR112018005771B1 (pt) 2023-12-05
AU2022202508A1 (en) 2022-05-12
WO2017050891A1 (en) 2017-03-30
CY1122837T1 (el) 2021-05-05
LT3352734T (lt) 2020-04-10
BR112018005771A2 (pt) 2018-10-09
SI3352734T1 (sl) 2020-07-31
CN108135834B (zh) 2021-07-27
IL257918A (en) 2018-05-31
US20220088020A1 (en) 2022-03-24
MY196541A (en) 2023-04-19

Similar Documents

Publication Publication Date Title
BR112017027056A2 (enExample)
BR112018005122A2 (enExample)
BR112017027018A2 (enExample)
BR112018005446A2 (enExample)
RU2018114922A3 (enExample)
BR112017026630A2 (enExample)
BR0009349B1 (enExample)
BR0008789B1 (enExample)
CN303070424S (enExample)
CN303070369S (enExample)
CN303069479S (enExample)
CN303069441S (enExample)
CN303068108S (enExample)
CN303068014S (enExample)
CN303062555S (enExample)
BR0302278B1 (enExample)
BR0210375B1 (enExample)
BR0009994B1 (enExample)
BR0009942B1 (enExample)
BR0009761B1 (enExample)
BR0009757B1 (enExample)
BR0009717B1 (enExample)
BR0009649B1 (enExample)
BR0009373B1 (enExample)
BR9915972B1 (enExample)